Dr. Brandon M. Henry received his MD from Jagiellonian University in 2016. He was a medical monitor and physician-scientist at Aixial Group from 2022 to 2024. He currently works as a researcher at Cincinnati Children’s Hospital Medical Center and is chair of the International Federation of Clinical Chemistry and Laboratory Medicine SARS-CoV-2 Variants Working Group. He provides scientific, clinical, operational, and regulatory strategy expertise to develop innovative, data-driven, and patient-centered solutions for cell and gene therapy clinical trials.